These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28423962)

  • 1. The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.
    Kwapisz L; Gregor J; Chande N; Yan B; Ponich T; Mosli M
    Scand J Gastroenterol; 2017 Aug; 52(8):846-850. PubMed ID: 28423962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease.
    Fernandes SR; Bernardo S; Saraiva S; Gonçalves AR; Moura Santos P; Valente A; Correia LA; Cortez-Pinto H; Magro F
    United European Gastroenterol J; 2024 May; 12(4):451-458. PubMed ID: 38093503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.
    Heilmann RM; Berghoff N; Mansell J; Grützner N; Parnell NK; Gurtner C; Suchodolski JS; Steiner JM
    J Vet Intern Med; 2018 Mar; 32(2):679-692. PubMed ID: 29460444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease.
    Costa MHM; Sassaki LY; Chebli JMF
    World J Gastroenterol; 2024 Jun; 30(24):3022-3035. PubMed ID: 38983953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
    Iordache MM; Belu AM; Vlad SE; Aivaz KA; Dumitru A; Tocia C; Dumitru E
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512053
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum calgranulin C as a non-invasive predictor of activity among inflammatory bowel disease.
    Rasmy HS; Elnakeeb NA; Mohamed MF; Elbaz HS
    Egypt J Immunol; 2024 Jul; 31(3):81-94. PubMed ID: 38995671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic.
    Jere M; Garrick V; Curtis L; Tayler R; Gervais L; Gerasimidis K; Hansen R
    BMJ Open Gastroenterol; 2021 May; 8(1):. PubMed ID: 33947712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P019 Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease.
    Gueorguieva I; Jacobs R; Piper M
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S5. PubMed ID: 37461939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morning light treatment for inflammatory bowel disease: a clinical trial.
    Cohen-Mekelburg S; Goldstein CA; Rizvydeen M; Fayyaz Z; Patel PJ; Berinstein JA; Bishu S; Cushing-Damm KC; Kim HM; Burgess HJ
    BMC Gastroenterol; 2024 May; 24(1):179. PubMed ID: 38778264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by "tight control"?
    Gonczi L; Bessissow T; Lakatos PL
    World J Gastroenterol; 2019 Nov; 25(41):6172-6189. PubMed ID: 31749591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals.
    Heinzel S; Jureczek J; Kainulainen V; Nieminen AI; Suenkel U; von Thaler AK; Kaleta C; Eschweiler GW; Brockmann K; Aho VTE; Auvinen P; Maetzler W; Berg D; Scheperjans F
    Sci Rep; 2024 Jun; 14(1):13513. PubMed ID: 38866914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of fecal S100A12 as a novel non-invasive diagnostic biomarker for pediatric inflammatory bowel disease: a systematic review and meta-analysis.
    Witarto BS; Visuddho V; Witarto AP; Sampurna MTA; Irzaldy A
    J Pediatr (Rio J); 2023; 99(5):432-442. PubMed ID: 37094752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin level is nonlinearly associated with GI pathogen detection in patients with and without inflammatory bowel disease.
    Newman KL; Higgins PDR
    J Clin Microbiol; 2023 Dec; 61(12):e0094623. PubMed ID: 38038481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing a New Flow Immune-Chromatography Fast Assay with a Random Access Semi-Automatic Chemiluminescent Immunoassay to Measure Fecal Calprotectin.
    Perets TT; Huta Y; Ashorov O; Seef A; Dickman R
    Ann Clin Lab Sci; 2023 Sep; 53(5):784-788. PubMed ID: 37945019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding.
    Saviano A; Petruzziello C; Zanza C; Candelli M; Gabrielli M; Migneco A; Franceschi F; Ojetti V
    Rev Recent Clin Trials; 2024; 19(1):70-75. PubMed ID: 37921137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.
    van den Brink G; Stapersma L; Bom AS; Rizopolous D; van der Woude CJ; Stuyt RJL; Hendriks DM; van der Burg JAT; Beukers R; Korpershoek TA; Theuns-Valks SDM; Utens EMWJ; Escher JC
    Inflamm Bowel Dis; 2019 Nov; 25(12):1945-1956. PubMed ID: 31050763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Calprotectin in Gastrointestinal Disease.
    Murray J; Kok KB; Ayling RM
    Clin Chem; 2023 Jul; 69(7):699-710. PubMed ID: 37228058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease.
    Caenepeel C; Falony G; Machiels K; Verstockt B; Goncalves PJ; Ferrante M; Sabino J; Raes J; Vieira-Silva S; Vermeire S
    Gastroenterology; 2024 Mar; 166(3):483-495. PubMed ID: 38096956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms.
    Shokri-Afra H; Alikhani A; Moradipoodeh B; Noorbakhsh F; Fakheri H; Moradi-Sardareh H
    Sci Rep; 2021 Nov; 11(1):22001. PubMed ID: 34753964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-Inflammatory Diet Is Correlated with High
    Rocha IMGD; Torrinhas R; Fonseca D; Lyra CO; de Sousa Alves Neri JL; Balmant BD; Callado L; Charlton K; Queiroz N; Waitzberg DL
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.